CytoDyn Inc (OTCQB:CYDY) CEO Nader Pourhassan tells Proactive the biotech has filed to uplist its stock to the tech-laded Nasdaq stock exchange. Pourhassan also updated investors on the company's coronavirus trials, and when a data readout is expected.
CytoDyn files to uplist to the Nasdaq, updates on coronavirus trials
Quick facts: CytoDyn Inc.
Price: 3.26 USD
Market Cap: $1.86 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of CytoDyn Inc. named herein, including the promotion by the Company of CytoDyn Inc. in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE